Diffrence between Sodium nitroprusside and NTG

Reading File

Finding Sources

Reading File

I now have comprehensive information from multiple authoritative textbooks. Here is the complete comparison:

Sodium Nitroprusside (SNP) vs. Nitroglycerin (NTG)

Mechanism of Action

Both are nitrovasodilators that ultimately work through the same final pathway: they release nitric oxide (NO) → activate guanylyl cyclase → increase cGMP → decrease intracellular calcium → relax vascular smooth muscle. However, their routes to NO differ:

SNP: Non-enzymatic reaction; in red blood cells, Fe²⁺ of oxyhemoglobin donates an electron to nitroprusside, releasing the active nitroso (NO) group along with 5 cyanide ions and methemoglobin.
NTG: Undergoes rapid reductive hydrolysis in the liver and blood by glutathione-organic nitrate reductase, producing nitric oxide. One metabolic product is nitrite, which can convert Hb to methemoglobin.

(Morgan & Mikhail's Clinical Anesthesiology, 7e)

Vascular Selectivity - The Core Difference

Property	SNP	NTG
Venous dilation	Yes (balanced)	Yes (predominant at low doses)
Arterial dilation	Yes (balanced)	Minimal at low doses; increases at higher doses
Net effect	Balanced arterial + venous dilator	Predominantly venodilator
Effect on preload	Reduces preload + afterload	Primarily reduces preload
Effect on afterload	Primarily reduces afterload	Minimal at low doses

Hemodynamic Effects

Parameter	SNP	NTG
Cardiac output	No change (or slight decrease) in normal heart; increases in heart failure via afterload reduction	Similar, but mainly via preload reduction
Heart rate	Reflex tachycardia (via renin + catecholamines)	Unchanged or minimally increased
BP reduction	Rapid, potent, precise titration	Effective but milder
Rebound hypertension	More likely on discontinuation	Less likely

Clinical Uses

Indication	SNP	NTG
Hypertensive emergency	First-line; gold standard	Yes, especially with ACS or pulmonary edema
Heart failure / cardiogenic shock	Useful - reduces both preload + afterload; improves forward flow	Useful - preferred in pulmonary edema (preload reduction)
Coronary artery disease / ACS	Contraindicated - causes coronary steal phenomenon	Preferred - redistributes flow to ischemic subendocardium; relieves coronary spasm
Myocardial ischemia relief	No (worsens it via steal)	Yes
Aortic dissection	Yes (combined with beta-blocker)	Alternative
Controlled hypotension in surgery	Yes	Less commonly used
Obstetrics (uterine relaxation)	No	Yes - 50-100 mcg IV bolus works as uterine relaxant
Acute MI	Relatively contraindicated	Preferred

(Barash 9e, Fuster and Hurst's The Heart 15e, Comprehensive Clinical Nephrology 7e)

Coronary Steal - Key Exam Point

SNP causes coronary steal: dilates non-stenotic vessels but cannot dilate already maximally dilated vessels beyond a stenosis → diverts flow away from ischemic areas → worsens ischemia.
NTG does the opposite - it redistributes coronary blood flow to ischemic subendocardial areas and relieves coronary artery spasm. This is why NTG is favored in ACS while SNP is relatively contraindicated.

Dosing & Administration

Parameter	SNP	NTG
Route	IV infusion only	IV infusion, sublingual, transdermal
Concentration	100 mcg/mL	100 mcg/mL
Infusion rate	0.25-5 mcg/kg/min (up to 10 mcg/kg/min short-term)	0.5-5 mcg/kg/min
Onset	1-2 minutes	~4 min sublingual; rapid IV
Offset	1-10 minutes after stopping	Similar rapid offset IV
Light sensitivity	Yes - must be covered with opaque foil	Yes
Monitoring	Intra-arterial BP monitoring recommended	Standard

Toxicity

SNP - Cyanide & Thiocyanate Toxicity

SNP releases 5 cyanide ions per molecule on metabolism.
Cyanide can: (1) bind methemoglobin (safe) → cyanmethemoglobin; (2) be converted by rhodanese (liver/kidney) with thiosulfate → thiocyanate (less toxic); (3) bind cytochrome oxidase → impairs O₂ utilization → cyanide toxicity.
Signs of cyanide toxicity: metabolic acidosis, arrhythmias, elevated venous O₂ content (cells can't use O₂), tachyphylaxis (first sign - resistance to hypotensive effect).
Risk factors: doses >500 mcg/kg/day, infusion >2 mcg/kg/min for hours, renal failure.
Treatment: sodium thiosulfate (sulfur donor), hydroxocobalamin (forms cyanocobalamin).
Thiocyanate toxicity (with prolonged use or renal failure): weakness, disorientation, psychosis, muscle spasms, convulsions; serum levels >10 mg/dL confirm it.
Rarely: methemoglobinemia, delayed hypothyroidism (thiocyanate inhibits iodide uptake).

NTG - Comparatively Safer

Main toxicities: headache (cerebral vessel dilation), hypotension.
Low-level methemoglobinemia possible (from nitrite metabolite) - treat with methylene blue 1-2 mg/kg IV.
No cyanide toxicity.
Inhibits platelet aggregation (rarely causes significant bleeding).

Pulmonary Effects (Both Drugs)

Both dilate pulmonary vasculature and can:

Inhibit hypoxic pulmonary vasoconstriction (HPV)
Increase V/Q mismatch and venous admixture
Decrease arterial oxygenation

Additionally, NTG relaxes bronchial smooth muscle.

Summary Table

Feature	SNP	NTG
Vasodilation pattern	Balanced A + V	Predominantly venous
Dominant effect	Afterload + preload	Preload
Coronary effect	Steal - harmful	Redistributes flow - beneficial
ACS / Ischemia	Contraindicated	Preferred
Pulmonary edema	Useful	Preferred
Toxicity	Cyanide, thiocyanate	Headache, methemoglobin (rare)
Monitoring required	Intra-arterial BP	Standard
Routes	IV only	IV / SL / transdermal
Tachyphylaxis	Yes (early cyanide sign)	Less prominent
Rebound hypertension	More likely	Less likely

(Sources: Katzung Basic & Clinical Pharmacology 16e; Morgan & Mikhail's Clinical Anesthesiology 7e; Barash Clinical Anesthesia 9e; Fuster & Hurst's The Heart 15e)

This is a shared conversation. Sign in to Orris to start your own chat.